{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:14:30Z","timestamp":1791414870590,"version":"4.3.3"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.2004","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T11:47:38Z","timestamp":1585828058000},"page":"e202004","source":"Crossref","is-referenced-by-count":33,"title":["Ischemic and Bleeding Events Among Patients With Acute Coronary Syndrome Associated With Low-Dose Prasugrel vs Standard-Dose Clopidogrel Treatment"],"prefix":"10.1001","volume":"3","author":[{"given":"Satoshi","family":"Shoji","sequence":"first","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuaki","family":"Sawano","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander T.","family":"Sandhu","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Heidenreich","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, California"},{"name":"Medical Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Shiraishi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Ikemura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Ueno","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Saiseikai Utsunomiya Hospital, Utsunomiya, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Hospital Organization Saitama Hospital, Wako, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Numasawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Ashikaga Hospital, Ashikaga, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Kohsaka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,4,2]]},"reference":[{"issue":"5","key":"zoi200104r1","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jtcvs.2016.07.044","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"152","author":"Levine","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"20","key":"zoi200104r2","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes.","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi200104r3","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.amjcard.2011.05.020","article-title":"Efficacy and safety of intensive antiplatelet therapy with prasugrel from TRITON-TIMI 38 in a core clinical cohort defined by worldwide regulatory agencies.","volume":"108","author":"Wiviott","year":"2011","journal-title":"Am J Cardiol"},{"issue":"7","key":"zoi200104r4","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1161\/CIR.0b013e318256f1e0","article-title":"2012 ACCF\/AHA focused update of the guideline for the management of patients with unstable angina\/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines.","volume":"126","author":"Jneid","year":"2012","journal-title":"Circulation"},{"issue":"4","key":"zoi200104r5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1161\/CIR.0b013e3182742c84","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines.","volume":"127","author":"O\u2019Gara","year":"2013","journal-title":"Circulation"},{"issue":"2","key":"zoi200104r6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"issue":"3","key":"zoi200104r7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"issue":"10","key":"zoi200104r8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrcardio.2014.104","article-title":"Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI.","volume":"11","author":"Levine","year":"2014","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"zoi200104r9","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.ahj.2015.09.017","article-title":"An international comparison of patients undergoing percutaneous coronary intervention: a collaborative study of the National Cardiovascular Data Registry (NCDR) and Japan Cardiovascular Database-Keio interhospital Cardiovascular Studies (JCD-KiCS).","volume":"170","author":"Kohsaka","year":"2015","journal-title":"Am Heart J"},{"issue":"5","key":"zoi200104r10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11886-014-0485-4","article-title":"\u201cEast Asian paradox\u201d: challenge for the current antiplatelet strategy of \u201cone-guideline-fits-all races\u201d in acute coronary syndrome.","volume":"16","author":"Jeong","year":"2014","journal-title":"Curr Cardiol Rep"},{"issue":"7","key":"zoi200104r11","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1253\/circj.CJ-13-1482","article-title":"Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: the PRASFIT-ACS study.","volume":"78","author":"Saito","year":"2014","journal-title":"Circ J"},{"issue":"14","key":"zoi200104r12","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.jacc.2016.01.049","article-title":"Performance and validation of the U.S. NCDR acute kidney injury prediction model in Japan.","volume":"67","author":"Inohara","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"zoi200104r13","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"key":"zoi200104r14","doi-asserted-by":"crossref","DOI":"10.1253\/circj.CJ-19-0133","article-title":"JCS 2018 Guideline on diagnosis and treatment of acute coronary syndrome.","author":"Kimura","year":"2019;83(5):1085-1196","journal-title":"Circ J"},{"issue":"11","key":"zoi200104r15","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1253\/circj.CJ-15-0112","article-title":"Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome\u2014randomized, double-blind, phase III PHILO study.","volume":"79","author":"Goto","year":"2015","journal-title":"Circ J"},{"key":"zoi200104r16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ijcard.2014.11.182","article-title":"Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: time for a reappraisal.","volume":"180","author":"Lip","year":"2015","journal-title":"Int J Cardiol"},{"issue":"13","key":"zoi200104r17","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.jacc.2016.06.062","article-title":"Thromboembolic, bleeding, and mortality risks of rivaroxaban and dabigatran in Asians with nonvalvular atrial fibrillation.","volume":"68","author":"Chan","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"zoi200104r18","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1161\/STROKEAHA.117.018773","article-title":"Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation.","volume":"48","author":"Cha","year":"2017","journal-title":"Stroke"},{"issue":"1","key":"zoi200104r19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jjcc.2017.05.003","article-title":"Comparison of prasugrel versus clopidogrel in Korean patients with acute myocardial infarction undergoing successful revascularization.","volume":"71","author":"Park","year":"2018","journal-title":"J Cardiol"},{"key":"zoi200104r20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ijcard.2016.04.125","article-title":"Inferiority of ticagrelor in the PHILO trial: play of chance in East Asians or nightmare confirmation of PLATO-USA?","volume":"215","author":"Serebruany","year":"2016","journal-title":"Int J Cardiol"},{"issue":"16","key":"zoi200104r21","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1056\/NEJMoa1908973","article-title":"Ticagrelor or prasugrel in patients with acute coronary syndromes.","volume":"381","author":"Sch\u00fcpke","year":"2019","journal-title":"N Engl J Med"},{"issue":"10","key":"zoi200104r22","first-page":"340","article-title":"Contemporary trends and outcomes associated with the preprocedural use of oral P2Y12 inhibitors in patients undergoing percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).","volume":"29","author":"Sukul","year":"2017","journal-title":"J Invasive Cardiol"},{"issue":"10","key":"zoi200104r23","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00380-018-1167-8","article-title":"The relationship between timing of prasugrel pretreatment and in-stent thrombus immediately after percutaneous coronary intervention for acute coronary syndrome: an optical coherence tomography study.","volume":"33","author":"Katayama","year":"2018","journal-title":"Heart Vessels"},{"issue":"9","key":"zoi200104r24","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.jcin.2017.02.015","article-title":"Impact of institutional and operator volume on short-term outcomes of percutaneous coronary intervention: a report from the Japanese Nationwide Registry.","volume":"10","author":"Inohara","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"25","key":"zoi200104r25","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1161\/CIR.0000000000000133","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"issue":"11","key":"zoi200104r26","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1056\/NEJMoa1308075","article-title":"Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes.","volume":"369","author":"Montalescot","year":"2013","journal-title":"N Engl J Med"},{"issue":"10","key":"zoi200104r27","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.amjcard.2014.02.037","article-title":"Evolution in practice patterns and long-term outcomes of coronary revascularization from bare-metal stent era to drug-eluting stent era in Japan.","volume":"113","author":"Shiomi","year":"2014","journal-title":"Am J Cardiol"},{"issue":"21","key":"zoi200104r28","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1056\/NEJMoa1908419","article-title":"Ticagrelor with or without aspirin in high-risk patients after PCI.","volume":"381","author":"Mehran","year":"2019","journal-title":"N Engl J Med"},{"issue":"10151","key":"zoi200104r29","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S0140-6736(18)31858-0","article-title":"Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial.","volume":"392","author":"Vranckx","year":"2018","journal-title":"Lancet"},{"issue":"12","key":"zoi200104r30","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1093\/eurheartj\/ehp110","article-title":"Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial.","volume":"30","author":"Mehran","year":"2009","journal-title":"Eur Heart J"},{"issue":"11","key":"zoi200104r31","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.111.060871","article-title":"Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention.","volume":"125","author":"Ndrepepa","year":"2012","journal-title":"Circulation"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2763784\/shoji_2020_oi_200104.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T11:47:41Z","timestamp":1585828061000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2763784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,2]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.2004","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,2]]}}}